Summary
An independent lab analysis was conducted on Nolvamed 20 (Tamoxifen Citrate 20 mg), manufactured by Deus Medical and submitted by DeusPower (reseller). The test, performed by Janoshik Analytical, aimed to verify the product’s authenticity and dosage accuracy.
Detailed Report
Product Information
- Manufacturer: Deus Medical
- Product Name: Nolvamed 20
- Active Ingredient: Tamoxifen Citrate
- Batch Number: DM27158
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Processing and Analysis
- Task Number: #09152
- Testing Ordered: 13 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DeusPower (reseller)
- Analysis Paid For By: DeusPower (reseller)
Lab Testing Results
- Claimed Dosage: 20 mg per pill
- Measured Dosage:
- First Pill: 19.59 mg
- Second Pill: 19.35 mg
Verification Details
- Verification URL: https://janoshik.com/tests/09152_I64T6HZK8GTM
Evaluation of Reseller-Submitted Testing
The tested sample demonstrates a concentration of 19.59 mg/ml, aligning well with the expected dosage level for a product marketed at 20 mg/ml.
Conclusion
The lab results confirm that Deus Medical’s Nolvamed 20 (Tamoxifen Citrate) is properly dosed, with slight variations within an acceptable range. While these findings support the product’s legitimacy, it’s worth noting that the test was submitted by a reseller, meaning that results may not fully reflect product consistency across all batches. Independent third-party testing across multiple batches is always recommended for further verification.
Disclaimer
This analysis is shared for educational and harm reduction purposes only. The results pertain to this specific batch and do not guarantee consistency across other batches. Consumers should exercise caution and seek independent testing whenever possible.
